What is the CVSS score of CVE-2017-6529?

CVE-2017-6529 has a CVSS 3.0 base score of 8.8 (High). CVSS vector: CVSS:3.0/AV:N/AC:L/PR:N/UI:R/S:U/C:H/I:H/A:H. EPSS exploitation probability: 4.5%.

Is there a public PoC exploit available for CVE-2017-6529?

Yes, a public proof-of-concept exploit is available for CVE-2017-6529. Prioritise patching immediately. EPSS: 4.5%.

Dnalims CVE-2017-6529

HIGH

Insufficient Session Expiration (CWE-613)

2017-03-09 cve@mitre.org

Information Disclosure Dnalims

8.8

CVSS 3.0 · NVD

Severity by source

NVD PRIMARY

8.8 HIGH

AV:N/AC:L/PR:N/UI:R/S:U/C:H/I:H/A:H

Primary rating from NVD · only source for this CVE.

CVSS VectorNVD

CVSS:3.0/AV:N/AC:L/PR:N/UI:R/S:U/C:H/I:H/A:H

Attack Vector

Network

Attack Complexity

Low

Privileges Required

None

User Interaction

Required

Scope

Unchanged

Confidentiality

High

Integrity

High

Availability

High

Lifecycle Timeline

CVE Published

Mar 09, 2017 - 19:59 cve.org

HIGH 8.8

DescriptionCVE.org

An issue was discovered in dnaTools dnaLIMS 4-2015s13. dnaLIMS is vulnerable to session hijacking by guessing the UID parameter.

AnalysisAI

An issue was discovered in dnaTools dnaLIMS 4-2015s13. Rated high severity (CVSS 8.8), this vulnerability is remotely exploitable, no authentication required, low attack complexity. Public exploit code available and no vendor patch available.

Technical ContextAI

This vulnerability is classified under CWE-613. An issue was discovered in dnaTools dnaLIMS 4-2015s13. dnaLIMS is vulnerable to session hijacking by guessing the UID parameter. Affected products include: Dnatools Dnalims.

RemediationAI

No vendor patch is available at time of analysis. Monitor vendor advisories for updates. Apply vendor patches when available. Implement network segmentation and monitoring as interim mitigations.